Partager

Latest Documents


  • 3-August-2018

    English

    OECD Reviews of Health Systems: A series of country reports

    Those in-depth studies of the health system of member countries focus on economic issues. They assess the performance of health systems in a comparative context, identify the main challenges faced by the country health system and put forward policy options to better meet them. Reviews are initiated at the request of the country to be examined and emphasis is placed on specific issues of key policy interest.

    Related Documents
  • 28-June-2018

    English, PDF, 1,423kb

    Spending on Health: Latest Trends

    Health spending back on a growth path after the slowdown following the financial crisis. Read about the latest health spending trends in this Policy Brief issued for the release of the database OECD Health Statistics 2018

    Related Documents
  • 12-June-2018

    English

    Care Needed - Improving the Lives of People with Dementia

    Across the OECD, nearly 19 million people are living with dementia. Millions of family members and friends provide care and support to loved ones with dementia throughout their lives. Globally, dementia costs over USD 1 trillion per year and represents one of the leading causes of disability for elderly adults. These numbers will continue to rise as populations age. Until a cure or disease-modifying treatment for dementia is developed, the progress of the disease cannot be stopped. This report presents the most up-to-date and comprehensive cross-country assessment of the state of dementia care in OECD countries. In recent years, OECD countries have enhanced their efforts to provide high-quality dementia care during diagnosis, early and advanced dementia, but improving measurement is necessary for enhancements in care quality and outcomes for people with dementia. The report advises a set of policies that can help countries to improve diagnosis, strengthen access to care services, improve the quality of care, and support the families and carers of people living with dementia. Measuring and comparing the services that are delivered to people with dementia and the outcomes they achieve is a crucial part of improving dementia care. Most health systems have very poor data on dementia care and  countries should work to strengthen the measurement of quality and outcomes of dementia care.
  • 5-June-2018

    English, PDF, 452kb

    Pharmaceutical Reimbursement and Pricing in Germany - Country profile

    This country profile was prepared to inform several OECD projects related to pharmaceutical policies and was updated in June 2018.

    Related Documents
  • 25-May-2018

    English

    OECD Reviews of Health Systems: Lithuania 2018

    The report analyses the performance of Lithuania’s health system which has been long characterised by its institutional stability and the steady pursuit of a policy agenda aimed at adapting it to the evolving burden of disease. Today, even if total spending on health is low and out-of-pocket payments represent nearly a third of it, the system ensures fairly equitable access to care. The main challenge to the system is that health outcomes still place Lithuania among the lowest ranked in the OECD. Efforts need to be geared more systematically towards strengthening public health and improving the quality of the services delivered at primary and hospital care levels.
  • 5-April-2018

    English

    Impact of Inequality on the Future Elderly – Workshop

    The workshop "Impact of Inequality on the Future Elderly – Policy Tools and Actions" will take place at the OECD Headquarters in Paris on April 5-6, 2018. Access the agenda, background documents, and register to attend.

    Related Documents
  • 27-February-2018

    English

    National Health Accounts of Kazakhstan

    This report assesses how Kazakhstan measures up in the development and application of its national health accounts, delivering a set of recommendations to improve the country’s health care financing information. As Kazakhstan has made significant economic progress over recent decades, health has risen on the policy agenda with a number of sector reforms introduced to modernise the system and improve the health of the population. Informing this agenda and monitoring progress towards health system goals requires accurate, timely and comprehensive information on health care financing and spending. A clear understanding of the resource allocations and drivers in the health sector is a prerequisite to support health system performance in Kazakhstan.
  • 27-February-2018

    English

    OECD Reviews of Health Systems: Kazakhstan 2018

    Kazakhstan has made significant economic progress over recent decades. Health has risen on the policy agenda with a number of sector reforms introduced to modernise the system and improve the health of the population. This review uses globally recognised frameworks and indicators to evaluate Kazakhstan’s overall health system as well as its primary care and hospital sectors. Data provided by Kazakhstan is used to benchmark the various dimensions of performance with that of OECD countries. While the review points to notable successes, Kazakhstan continues to face challenges to improve the accessibility, equity, and efficiency of health services. To strengthen health system performance, the report points to key actions that Kazakhstan should consider prioritising in the coming years.
  • 26-February-2018

    English, PDF, 1,465kb

    Feasibility Study On Health Workforce Skills Assessment

    This study reviews the status of existing surveys that measure health professional skills, and identifies gaps where more attention and resources will be needed to generate policy-relevant evidence on skills requirements, skills use and skills mismatch in healthcare settings.

    Related Documents
  • 16-February-2018

    English

    How Pharmaceutical Systems are organized in Asia and the Pacific

    There are important differences in the markets for medicines in countries in Asia and the Pacific in this study. These are mainly due to the political, financial and regulatory environments as well as characteristics of the pharmaceutical manufacturing industry. However, all countries face the test of transition brought about by demographic changes, shifting epidemiological trends and increasing inequities, among others. As with other regions of the world, a characteristic of lower- and upper-middle-income countries is that pharmaceuticals account for a high proportion of health expenditures. Medicines account for a larger share of the health budgets in resource-constrained countries.
  • << < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 > >>